prednisolone has been researched along with Endometrial Neoplasms in 5 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Individuals presenting with ovarian or endometrial cancer received four or five weekly doses of 1." | 2.67 | Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug. ( Akerlund, M; Breeze, A; Filipowska, D; Filipowski, T; Kazanowska, W; Lapinjoki, S; Laudanski, T; Morelowska, B, 1992) |
| "A 71-year-old female with advanced endometrial cancer was treated with pegfilgrastim." | 1.51 | Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor. ( Hirata, S; Mokuda, S; Sugiyama, E; Yoshida, Y; Yukawa, K, 2019) |
| "The association of systemic lupus erythematosus (SLE) and solid tumors is infrequent." | 1.29 | [A dual occurrence of endometrial and gastric adenocarcinomas in systemic lupus erythematosus]. ( Akama, T; Iijima, T; Kashiwagi, H; Nakahara, A; Suzuki, H; Takemura, H; Yamane, K; Yuhara, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yukawa, K | 1 |
| Mokuda, S | 1 |
| Yoshida, Y | 1 |
| Hirata, S | 1 |
| Sugiyama, E | 1 |
| Kasuya, A | 1 |
| Hamaguchi, Y | 1 |
| Fujimoto, M | 1 |
| Tokura, Y | 1 |
| Saito, W | 1 |
| Kase, S | 1 |
| Yoshida, K | 1 |
| Ohguro, H | 1 |
| Yokoi, M | 1 |
| Iwaki, H | 1 |
| Ohno, S | 1 |
| Yamane, K | 1 |
| Iijima, T | 1 |
| Nakahara, A | 1 |
| Takemura, H | 1 |
| Yuhara, T | 1 |
| Akama, T | 1 |
| Suzuki, H | 1 |
| Kashiwagi, H | 1 |
| Filipowska, D | 1 |
| Filipowski, T | 1 |
| Morelowska, B | 1 |
| Kazanowska, W | 1 |
| Laudanski, T | 1 |
| Lapinjoki, S | 1 |
| Akerlund, M | 1 |
| Breeze, A | 1 |
1 trial available for prednisolone and Endometrial Neoplasms
| Article | Year |
|---|---|
Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug.
Topics: Adenocarcinoma; Adrenal Cortex; Chenodeoxycholic Acid; Cystadenocarcinoma; Drug Carriers; Drug Thera | 1992 |
4 other studies available for prednisolone and Endometrial Neoplasms
| Article | Year |
|---|---|
Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor.
Topics: Aged; Aorta, Thoracic; Endometrial Neoplasms; Female; Filgrastim; Giant Cell Arteritis; Glucocortico | 2019 |
TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody.
Topics: Anti-Inflammatory Agents; Autoantibodies; Carcinoma; Dermatomyositis; Endometrial Neoplasms; Female; | 2013 |
Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
Topics: Aged; Autoantibodies; Autoantigens; Blotting, Western; Cell Proliferation; Electroretinography; Endo | 2005 |
[A dual occurrence of endometrial and gastric adenocarcinomas in systemic lupus erythematosus].
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Endometrial Neoplasms; Female; Humans; Lupus Erythematosus | 1996 |